| Consensus guidelines for the definition, detection and interpretation of immunogenic cell death L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ... Journal for immunotherapy of cancer 8 (1), 2020 | 781 | 2020 |
| Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing SR Gameiro, ML Jammed, MM Wattenberg, KY Tsang, S Ferrone, ... Oncotarget 5 (2), 403, 2014 | 412 | 2014 |
| Chemotherapy‐induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death JW Hodge, CT Garnett, B Farsaci, C Palena, KY Tsang, S Ferrone, ... International Journal of Cancer, 2013 | 292 | 2013 |
| Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances H Lind, SR Gameiro, C Jochems, RN Donahue, J Strauss, JL Gulley, ... Journal for immunotherapy of cancer 8 (1), 2020 | 195 | 2020 |
| M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine KM Knudson, KC Hicks, X Luo, JQ Chen, J Schlom, SR Gameiro Oncoimmunology 7 (5), e1426519, 2018 | 187 | 2018 |
| If we build it they will come: targeting the immune response to breast cancer ME Gatti-Mays, JM Balko, SR Gameiro, HD Bear, S Prabhakaran, J Fukui, ... NPJ breast cancer 5 (1), 37, 2019 | 169 | 2019 |
| The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors JW Hodge, A Ardiani, B Farsaci, AR Kwilas, SR Gameiro Seminars in oncology 39 (3), 323-339, 2012 | 166 | 2012 |
| Tumor cells surviving exposure to proton or photon radiation share a common immunogenic modulation signature, rendering them more sensitive to T cell–mediated killing SR Gameiro, AS Malamas, MB Bernstein, KY Tsang, A Vassantachart, ... International Journal of Radiation Oncology* Biology* Physics 95 (1), 120-130, 2016 | 139 | 2016 |
| Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation JW Hodge, HJ Sharp, SR Gameiro Cancer Biotherapy and Radiopharmaceuticals 27 (1), 12-22, 2012 | 123 | 2012 |
| Radiation-induced modulation of costimulatory and coinhibitory T-cell signaling molecules on human prostate carcinoma cells promotes productive antitumor immune interactions MB Bernstein, CT Garnett, H Zhang, A Velcich, MM Wattenberg, ... Cancer Biotherapy and Radiopharmaceuticals 29 (4), 153-161, 2014 | 115 | 2014 |
| Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy KM Knudson, KC Hicks, S Alter, J Schlom, SR Gameiro Journal for immunotherapy of cancer 7, 1-16, 2019 | 94 | 2019 |
| Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells SR Gameiro, AS Malamas, KY Tsang, S Ferrone, JW Hodge Oncotarget 7 (7), 7390, 2016 | 93 | 2016 |
| Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway A Ardiani, SR Gameiro, AR Kwilas, RN Donahue, JW Hodge Oncotarget 5 (19), 9335, 2014 | 85 | 2014 |
| Sublethal exposure to alpha radiation (223Ra dichloride) enhances various carcinomas’ sensitivity to lysis by antigen-specific cytotoxic T lymphocytes through calreticulin … AS Malamas, SR Gameiro, KM Knudson, JW Hodge Oncotarget 7 (52), 86937, 2016 | 80 | 2016 |
| Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression SR Gameiro, JP Higgins, MR Dreher, DL Woods, G Reddy, BJ Wood, ... PloS one 8 (7), e70417, 2013 | 75 | 2013 |
| Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer DB Page, H Bear, S Prabhakaran, ME Gatti-Mays, A Thomas, E Cobain, ... NPJ breast cancer 5 (1), 34, 2019 | 71 | 2019 |
| Exploitation of differential homeostatic proliferation of T-cell subsets following chemotherapy to enhance the efficacy of vaccine-mediated antitumor responses SR Gameiro, JA Caballero, JP Higgins, D Apelian, JW Hodge Cancer Immunology, Immunotherapy 60, 1227-1242, 2011 | 71 | 2011 |
| Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication LA Horn, PL Chariou, SR Gameiro, H Qin, M Iida, K Fousek, TJ Meyer, ... The Journal of clinical investigation 132 (8), 2022 | 65 | 2022 |
| Rationale for IL-15 superagonists in cancer immunotherapy KM Knudson, JW Hodge, J Schlom, SR Gameiro Expert Opinion on Biological Therapy 20 (7), 705-709, 2020 | 64 | 2020 |
| Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types KC Hicks, M Fantini, RN Donahue, A Schwab, KM Knudson, SR Tritsch, ... Oncoimmunology 7 (11), e1466018, 2018 | 63 | 2018 |
